Comparison of glyburide with metformin in treating gestational diabetes mellitus: a systematic review and meta-analysis (Q38488606)

3 September 2017

0 references

1 reference

title

Comparison of glyburide with metformin in treating gestational diabetes mellitus: a systematic review and meta-analysis (English)

1 reference

3 September 2017

0 references

1 reference

Muhammad Amin

1

1 reference

3 September 2017

Naeti Suksomboon

series ordinal

2

1 reference

3 September 2017

Nalinee Poolsup

series ordinal

3

1 reference

3 September 2017

Obaidullah Malik

series ordinal

4

1 reference

3 September 2017

publication date

1 June 2015

1 reference

Clinical Drug Investigation

3 September 2017

published in

1 reference

3 September 2017

volume

35

1 reference

3 September 2017

issue

6

1 reference

3 September 2017

page(s)

343-351

1 reference

Practice Bulletin No. 137: Gestational diabetes mellitus

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Hyperglycemia and adverse pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Gestational diabetes: the consequences of not treating

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

The macrosomic fetus: a challenge in current obstetrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Through the looking glass at early-life exposures and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Borderline gestational diabetes mellitus and pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Gestational diabetes: the need for a common ground

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Standards of medical care in diabetes--2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Metformin compared with glyburide in gestational diabetes: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Comparison of neonatal outcomes in women with gestational diabetes with moderate hyperglycaemia on metformin or glibenclamide--a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Population pharmacokinetics of metformin in late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Metformin versus insulin for the treatment of gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Glyburide as treatment option for gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

A comparison of glyburide and insulin in women with gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Overweight and obese in gestational diabetes: the impact on pregnancy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Efficacy and safety of oral antidiabetic drugs in comparison to insulin in treating gestational diabetes mellitus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Metformin vs insulin in the management of gestational diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Suspected macrosomia? Better not tell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-015-0289-3

Infant overweight is associated with delayed motor development

21 January 2018

1 reference

12 December 2020

Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer

1 reference

12 December 2020

Growth and neurodevelopmental outcome of children born to mothers with pregestational and gestational diabetes

1 reference

12 December 2020

Metformin compared with insulin in the management of gestational diabetes mellitus: a randomized clinical trial

1 reference

12 December 2020

Weight and length at birth of infants of diabetic mothers

1 reference

12 December 2020

Comparison of glyburide versus insulin in management of gestational diabetes mellitus

1 reference

12 December 2020

Diagnosis and classification of diabetes mellitus

1 reference

12 December 2020

Perinatal impact of the use of metformin and glyburide for the treatment of gestational diabetes mellitus

1 reference

12 December 2020

Point: Oral hypoglycemic agents should not be used to treat diabetic pregnant women

1 reference

12 December 2020

10.1007/S40261-015-0289-3

Identifiers

DOI

1 reference

3 September 2017

1 reference